153 related articles for article (PubMed ID: 6349536)
21. Influence of nutritional treatment on the postoperative course in patients with gastric cancer.
Karcz W; Głuszek S; Kot M; Matykiewicz J
Adv Med Sci; 2006; 51():278-82. PubMed ID: 17357326
[TBL] [Abstract][Full Text] [Related]
22. [Antitumor activity of bacterial fractions and related synthetic compounds].
Azuma I; Yamamura Y
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2691-9. PubMed ID: 6508322
[TBL] [Abstract][Full Text] [Related]
23. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
24. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
25. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM
Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632
[TBL] [Abstract][Full Text] [Related]
26. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
27. [A randomized controlled study of adjuvant immunotherapy with N-CWS for head and neck malignancies].
Sakai S; Itoh M; Matsunaga T; Yoshida J; Sato T; Miyahara Y; Matsunaga T; Hyoh Y; Ohyama K; Katsuta K
Gan No Rinsho; 1985 Sep; 31(11):1353-61. PubMed ID: 4068237
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological features, surgical management, and disease outcome of perforated gastric cancer.
Jwo SC; Chien RN; Chao TC; Chen HY; Lin CY
J Surg Oncol; 2005 Sep; 91(4):219-25. PubMed ID: 16121341
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant chemoimmunotherapy for gastric carcinoma.
Makowka L; Falk RE; Ambus U; Bugala R; Landi S
Can J Surg; 1980 Sep; 23(5):429-31. PubMed ID: 6159957
[TBL] [Abstract][Full Text] [Related]
30. Surgery for gastric cancer in patients older than 80 years of age.
Hanazaki K; Wakabayashi M; Sodeyama H; Miyazawa M; Yokoyama S; Sode Y; Kawamura N; Ohtsuka M; Miyazaki T
Hepatogastroenterology; 1998; 45(19):268-75. PubMed ID: 9496525
[TBL] [Abstract][Full Text] [Related]
31. Influence of overweight on patients with gastric cancer after undergoing curative gastrectomy: an analysis of 689 consecutive cases managed by a single center.
Ojima T; Iwahashi M; Nakamori M; Nakamura M; Naka T; Ishida K; Ueda K; Katsuda M; Iida T; Tsuji T; Yamaue H
Arch Surg; 2009 Apr; 144(4):351-8; discussion 358. PubMed ID: 19380649
[TBL] [Abstract][Full Text] [Related]
32. Comparative study on antitumor effect of cell-wall skeleton of Mycobacterium bovis BCG and Nocardia rubra, with reference to T-cell dependency and independency.
Yanagawa E; Yasumoto K; Ohta M; Nomoto K; Azuma I; Yamamura Y
Gan; 1979 Apr; 70(2):141-6. PubMed ID: 381087
[TBL] [Abstract][Full Text] [Related]
33. Gastric cancer in the young.
Lai IR; Lee WJ; Chen CN; Lee PH; Chang KJ; Chang-Yu S; Chen KM
Hepatogastroenterology; 1997; 44(18):1641-5. PubMed ID: 9427036
[TBL] [Abstract][Full Text] [Related]
34. Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM.
An JY; Ha TK; Noh JH; Sohn TS; Kim S
Arch Surg; 2009 Jan; 144(1):38-45; discussion 45. PubMed ID: 19153323
[TBL] [Abstract][Full Text] [Related]
35. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of adoptive immunotherapy with tumor-associated lymphocytes in patients with advanced gastric cancer: a randomized trial.
Kono K; Takahashi A; Ichihara F; Amemiya H; Iizuka H; Fujii H; Sekikawa T; Matsumoto Y
Clin Cancer Res; 2002 Jun; 8(6):1767-71. PubMed ID: 12060615
[TBL] [Abstract][Full Text] [Related]
37. [Second primary malignancy after surgical adjuvant therapy for gastric cancer].
Fujimoto J
Gan To Kagaku Ryoho; 1999 Nov; 26(13):2009-14. PubMed ID: 10584564
[TBL] [Abstract][Full Text] [Related]
38. [Long-term survival of curatively operated gastric cancer: influence of the gender and splenectomy].
Schafmayer C; Jürgens G; Jürgens I; Klomp HJ; Fändrich F; Kahlke V
Zentralbl Chir; 2007 Dec; 132(6):515-22. PubMed ID: 18098079
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of self-expandable metallic stent plus chemotherapy for metastatic gastric cancer with pyloric stenosis.
Shimura T; Kataoka H; Sasaki M; Yamada T; Hayashi K; Togawa S; Okumura F; Kubota E; Ohara H; Joh T
J Gastroenterol Hepatol; 2009 Aug; 24(8):1358-64. PubMed ID: 19467141
[TBL] [Abstract][Full Text] [Related]
40. Postoperative chemotherapy in elderly patients with advanced gastric cancer.
Hanazaki K; Mochizuki Y; Igarashi J; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T; Amano J
Hepatogastroenterology; 2000; 47(36):1761-4. PubMed ID: 11149051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]